ASX:MVPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
MEDICAL DEVELOPMENTS INTERNATNL ORD
$0.520
+$0.135 (+35.06%)
Day Range
$0.415 - $0.525
52 Week Range
$0.365 - $0.765
Volume
1.22M
Avg Volume (10D)
106.87K
Market Cap
$58.58M
P/E Ratio
458.33
Price Chart
Market Statistics
Open$0.415
Previous Close$0.385
Day High$0.525
Day Low$0.415
52 Week High$0.765
52 Week Low$0.365
Valuation
Market Cap58.58M
Shares Outstanding112.66M
P/E Ratio (Annual)458.33
Price to Book0.79
Trading Activity
Volume1.22M
Value Traded581.75K
Bid$0.510 × 1,000
Ask$0.525 × 250,000
Performance
1 Day0.00%
5 Day0.00%
13 Week-25.24%
52 Week-9.41%
YTD-30.63%
Technical Indicators
RSI (14)74.44
50-Day SMA$0.415
200-Day SMA$0.552
Latest News
Biotechnology
Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
1 min read
Biotechnology
Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]
4 min read
